Trial intelligence / Profile preview

HIPEC in Locally Advanced Colorectal Cancer

NCT02830139Phase 2Completed

Sponsor
Wuhan University
Start
Jul 2016
Primary completion
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of paclitaxel, fluorouracil in colorectal cancer (CRC), sponsored by Wuhan University. Started Jul 2016; status: completed.

02

Drugs

paclitaxelfluorouracil
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT02830139.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02830139.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call